(Q45401455)

14 December 2017

title

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy (English)

1 reference

14 December 2017

1 reference

1 reference

6

Henry Erlich

1 reference

14 December 2017

Hugo R Rosen

1

1 reference

14 December 2017

Scott J Weston

2

1 reference

14 December 2017

KyungAh Im

3

1 reference

14 December 2017

Huiying Yang

4

1 reference

14 December 2017

James R Burton

5

1 reference

14 December 2017

Jared Klarquist

7

1 reference

14 December 2017

Steven H Belle

8

1 reference

14 December 2017

Virahep-C Study Group

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

46

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

350-358

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

14 December 2017

cites work

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

7 January 2021

Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection

1 reference

7 January 2021

The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

7 January 2021

Ethnicity and hepatitis C virus infection

1 reference

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

7 January 2021

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans

1 reference

7 January 2021

Hepatitis C in African Americans: summary of a workshop

1 reference

7 January 2021

Racial differences in liver inflammation and fibrosis related to chronic hepatitis C.

1 reference

7 January 2021

Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group

1 reference

7 January 2021

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

7 January 2021

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

7 January 2021

Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.

1 reference

7 January 2021

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

7 January 2021

Histopathology of Hepatitis C Virus Infection

1 reference

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

7 January 2021

A modified poisson regression approach to prospective studies with binary data

1 reference

7 January 2021

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

1 reference

7 January 2021

Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes

1 reference

7 January 2021

MHC class I peptides as chemosensory signals in the vomeronasal organ.

1 reference

7 January 2021

Immune evasion versus recovery after acute hepatitis C virus infection from a shared source

1 reference

7 January 2021

Cell-mediated immunity and the outcome of hepatitis C virus infection

1 reference

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

7 January 2021

The importance of assessing effect modification when asserting racial differences in associations between human leukocyte antigen class II alleles and hepatitis C virus outcomes

1 reference

7 January 2021

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

1 reference

7 January 2021

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

1 reference

7 January 2021

Immunological memory in humans

1 reference

7 January 2021

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

1 reference

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

7 January 2021

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

1 reference

7 January 2021

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

1 reference

7 January 2021

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.

1 reference

7 January 2021

Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21714

1 reference

14 December 2017

1 reference